Navigation Links
DURECT Announces Changes to its Board of Directors
Date:9/27/2013

CUPERTINO, Calif., Sept. 27, 2013 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Jay Shepard will join its Board of Directors effective September 26, 2013.  Separately, Michael Casey has made the decision to retire from the Board of Directors effective December 31, 2013. 

(Logo: http://photos.prnewswire.com/prnh/20020717/DRRXLOGO)

Mr. Shepard has over 30 years' experience in the pharmaceutical, biotechnology and drug delivery fields.  Mr. Shepard currently serves as an Executive Partner at Sofinnova Ventures.  From 2010 until 2012, he was President and CEO of NextWave Pharmaceuticals, a pediatric focused therapeutics company which was acquired in November 2012 by Pfizer in a deal valued up to $700 million shortly after NextWave obtained FDA approval for Quillivant XR, a treatment for Attention-Deficit Hyperactivity Disorder (ADHD).  While serving at NextWave, Mr. Shepard maintained a strategic adviser relationship with Sofinnova Ventures, which he joined in 2008 as an Executive in Residence.  Prior to Sofinnova Ventures, Mr. Shepard was President and CEO of Ilypsa, a nephrology therapeutics company acquired by Amgen for $420 million.  He then helped with Ilypsa's spin-out company, Relypsa, serving as interim President and CEO.  Before Ilypsa, Mr. Shepard served as Vice President, Commercial Operations at Telik, where he was responsible for all activities related to market preparation toward the launch of the company's lead oncology compounds.  Previously, he was Vice President of ALZA Pharmaceuticals' Oncology Business Unit, having held leadership positions of increasing responsibility in the establishment and operation of ALZA's spec
'/>"/>

SOURCE DURECT Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DURECT Corporation Announces Second Quarter 2013 Financial Results and Update of Programs
2. DURECT Corporation Announces First Quarter 2013 Financial Results and Update of Programs
3. DURECT Corporation Invites You to Join its First Quarter 2013 Earnings Conference Call
4. DURECT Corporation Invites You to Join its Fourth Quarter 2012 Earnings Conference Call
5. DURECT Corporation Announces Third Quarter 2012 Financial Results and Update of Programs
6. DURECT Corporation Invites You to Join its Third Quarter 2012 Earnings Conference Call
7. DURECT to Participate in Upcoming Healthcare Conferences
8. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
9. DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs
10. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
11. Trianni Announces Launch of Its Optimized Human Antibody Transgenic Mouse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ... European Commission (the "EC") to extend the deadline for ... by a limited number of days in order to ... Deadline extensions are not uncommon in such in-depth ... authorities to facilitate their review of the pending transaction ...
(Date:11/18/2014)... Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that ... 2014 at 9:00 a.m. Eastern Time to discuss the ISIS-FXI ... Society of Hematology Annual Meeting and Exposition.  ... or access the webcast at www.isispharm.com .  A webcast ... same address. ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:11/18/2014)... 18, 2014  AgeneBio, a pharmaceutical company developing ... restore brain function, today announced that the Company,s ... , PhD, has received the Society for Neuroscience,s ... 35 years, Dr. Gallagher,s research at Johns Hopkins ... Hill has led to advancements in the field ...
Breaking Medicine Technology:Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 2Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 3Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 4Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc. 5Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 2Isis Pharmaceuticals to Host Webcast to Discuss ISIS-FXI Rx Data Presented at the ASH Annual Meeting 3AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 2AgeneBio Founder and Chief Scientific Officer Receives Society for Neuroscience's Mika Salpeter Lifetime Achievement Award 3
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. ... verge of burning out are more likely to develop heart ... vital exhaustion -- a toxic combination of fatigue, irritability and ... heart disease, researchers report. "In our increasingly busy lives, ... when that stress is left unchecked for a period of ...
(Date:11/18/2014)... By Dennis Thompson HealthDay ... doctor from Sierra Leone who became infected with Ebola in his ... Dr. Martin Salia had arrived Saturday at Nebraska Medical Center ... at a hospital in Sierra Leone,s capital city of Freetown. ... that have been ravaged by the Ebola outbreak that began last ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, 2014 (HealthDay ... them track how many calories they consume each day, but ... one after their doctor recommended it did not lose any ... using such apps as weight-loss tools. Some participants were barely ... varied, the researchers noted, and they added that they believe ...
(Date:11/17/2014)... 2014 Vernon Brewer, Founder and President of ... two weeks and saw firsthand the devastating holocaust that ISIS ... Iraq and Syria. , “‘Holocaust’ is not a term I ... or driven thousands of Christians and members of other faiths ... is desperate. As ISIS expands, they continue to kill ...
(Date:11/17/2014)... November 17, 2014 Home Care Assistance ... provider of non-medical, in-home senior care, is advising seniors ... , Aging typically weakens the immune system and makes ... the flu. This is a greater concern at this ... more prevalent; during last year’s influenza season (November to ...
Breaking Medicine News(10 mins):Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 3
... smell better is due to the boding of the hormone, ... age are far better in sensing the fragrance than men ... said: "Some studies have shown that during ovulation, there's a ... nose is the same in women as men. Theories have ...
... common problem for heavy drinkers and the scientist have found ... the potentialities of a night out. ,Researchers at the ... in Minnesota say the effect of alcohol on blood vessels ... healthy young adults, that blood vessels do not strengthen so ...
... weekend alcohol flings and the stress of going back to ... heart attack. A 7 year study carried out in Australia ... attacks on a Monday than any other day. ,Experts ... exorbitant drinking and coronary heart disease.//They suggested the stresses of ...
... putting its best foot forward in completing its ... company promote Zyban, its anti-smoking drug. Glaxo is ... of its policy, along with providing teams to ... of the corporate, which have negotiated for this ...
... prevented in prostate cancer patients who are undergoing ... The researchers at the New York Cornell Medical ... be considered as a monotherapy in men who ... the researchers evaluated 54 patients with clinically localised ...
... Brain surgery, endoscopies and other complicated medical procedures could ... using computers. Scientists from the University of California, Los ... interact with their environment and are attempting to design ... surgeons routinely use technology that is capable of producing ...
Cached Medicine News:
... Diagnostic, Non-Donor Screen. Vironostika HIV assays ... for additional testing and confirmation. Vironostika ... assay for the detection of antibody to ... spots. Oral Fluid Vironostika HIV-1 Microelisa ...
... OraSure HIV-1 Oral Specimen Collection Device is a ... HIV-1 antibodies. Testing with the OraSure HIV-1 Oral ... and has been shown to be more than ... treated cotton fiber pad attached to a nylon ...
... Angle CHS System takes the time proven ... , ,The VHS® Supracondylar Cable Plate is ... distal femur fractures including periprosthetic fractures. The ... variable angle of the barrel and the ...
Coronet Vacuum Trephine - All metal, ergonomic design and ultra sharp blade with cross hairs....
Medicine Products: